Invention Grant
- Patent Title: Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
-
Application No.: US17327337Application Date: 2021-05-21
-
Publication No.: US11925638B2Publication Date: 2024-03-12
- Inventor: Tomohiro Eguchi , Masamichi Mori , Yoko Yamaki
- Applicant: ASTELLAS PHARMA INC.
- Applicant Address: JP Tokyo
- Assignee: ASTELLAS PHARMA INC.
- Current Assignee: ASTELLAS PHARMA INC.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP 14019226 2014.02.04
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/517 ; A61K31/5377 ; A61K45/06
Abstract:
A pharmaceutical composition is suitable for treating AXL-related cancer. The cancer can be cancer with high expression of AXL. The cancer can also be cancer which has acquired resistance by the activation of AXL against therapy with an anticancer agent. Specific diamino heterocyclic carboxamide compounds have an AXL inhibitory action, and pharmaceutical compositions comprising these compounds as an active ingredient have a therapeutic effect on AXL-related cancer. This AXL-related cancer can be cancer with high expression of AXL and/or cancer which has acquired resistance by the activation of AXL against therapy with an anticancer agent.
Public/Granted literature
- US20210290618A1 PHARMACEUTICAL COMPOSITION COMPRISING DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT Public/Granted day:2021-09-23
Information query
IPC分类:
